Historical Evolution and Provider Awareness of Inactive Ingredients in Oral Medications
Purpose: A multitude of different versions of the same medication with different inactive ingredients are currently available. It has not been quantified how this has evolved historically. Furthermore, it is unknown whether healthcare professionals consider the inactive ingredient portion when presc...
Main Authors: | Reker, Daniel, Blum, Steven M., Wade, Peter, Steiger, Christoph Winfried Johannes, Traverso, Carlo Giovanni |
---|---|
Other Authors: | MIT-IBM Watson AI Lab |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2020
|
Online Access: | https://hdl.handle.net/1721.1/128461 |
Similar Items
-
“Inactive” ingredients in oral medications
by: Reker, Daniel, et al.
Published: (2020) -
Biologic excipients: Importance of clinical awareness of inactive ingredients.
by: Yelena Ionova, et al.
Published: (2020-01-01) -
Enabling deep-tissue networking for miniature medical devices
by: Ma, Yunfei, et al.
Published: (2020) -
Recent confusion and ongoing actions related to the FDA’s Inactive Ingredient Database (IID) - What should be included in the ANDA?
by: David R. Schoneker
Published: (2016-10-01) -
Quantifying the value of orally delivered biologic therapies: A cost-effectiveness analysis of oral semaglutide
by: Abramson, Alex, et al.
Published: (2022)